Sec. 763. Report on use of oculometric brain health assessment systems for Department of Defense
398 words·~2 min read·
/bill/119/hr/3838/eh/section-763·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Under Secretary of Defense for Personnel and Readiness, in consultation with the Surgeons General of the Armed Services, or other relevant Department of Defense organizations identified by the Secretary of Defense, shall conduct an assessment on the use of oculometric biomarker monitoring technologies to support mission sets of the Department of Defense. The assessment conducted under subsection
(a)shall contain each of the following elements: The anticipated mid- and long-term utility of oculometric monitoring systems in optimizing human performance and enhancing U.S. military readiness and operational effectiveness. The ability of oculometric biomarker monitoring to detect fatigue, stress, traumatic brain injury, substance use disorder, and post-traumatic stress disorder in servicemembers, including in deployed environments. The effectiveness of such systems in reducing operational risk and enhancing cognitive resilience in combat and training settings. The role of oculometric biomarker monitoring in early detection of traumatic brain injury, substance use disorder, and post-traumatic stress disorder for active-duty personnel and veterans, including the utility of monitoring recovery and tailoring rehabilitation plans to individual servicemembers. Whether use of oculometric monitoring systems enhances mission readiness by providing real-time physiological and cognitive performance feedback. The potential of such systems to reduce costly attrition and improve decision-making under stress. Opportunities for integration with existing or planned medical, training, and readiness systems of the Department. The role of brain health monitoring technologies in protecting against performance degradation that may jeopardize mission success. Potential contributions of oculometric technologies to allied and partner nation capacity building. A review of outcomes from existing trials funded by the Department of oculometric biomarker monitoring technologies with the Air Force, Army, and the National Aeronautics and Space Administration. Identification of any gaps in such trials requiring further research, development, testing, and evaluation. Not later than March 1, 2026, the Under Secretary of Defense for Personnel and Readiness shall submit to the appropriate congressional committees a report containing— the assessment required under subsection (a); and recommendations on the optimal use of oculometric biomarker monitoring technologies to support mission sets of the Department of Defense, including on— expansion of device deployment across field units and military medical centers; further operational trials to benchmark injury thresholds and readiness indicators; and integration of cognitive and neurological health metrics into existing health and readiness reporting systems of the Department. The report required by subsection
(c)shall be submitted in an unclassified form, but may include a classified annex.